Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-05-22

Clinical Trial Update: Moxifloxacin As Part of a Multi-Drug Regimen For Tuberculosis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating moxifloxacin as part of a multi-drug regimen for tuberculosis; results were posted in 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Moxifloxacin (moxifloxacin)

Snippet

Sponsor: Johns Hopkins University | Conditions: Tuberculosis | Phase 2 | Status: COMPLETED | Results posted: 2013-05-22